Les inhibiteurs de mTOR

ISSN： 1292-3818

Source： Oncologie, Vol.8, Iss.9, 2006-11, pp. : 821-827

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Apport des antiangiogéniques et des inhibiteurs de mTOR dans le traitement des tumeurs endocrines digestives

By Walter T. Lombard-Bohas C.

Oncologie, Vol. 12, Iss. 10, 2010-10 ,pp. : 636-640

Springer Publishing Company

Access to resources Recommend Favorite

Updates of mTOR Inhibitors

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 7, 2010-09 ,pp. : 571-581

Bentham Science Publishers

Access to resources Recommend Favorite

Role of mTOR in Hematological Malignancies

Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 211-218

Bentham Science Publishers

Access to resources Recommend Favorite

Role of mTOR inhibitor in cholangiocarcinoma cell progression

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 854-860

Spandidos Publications

Access to resources Recommend Favorite

Mechanisms of mTOR inhibitor resistance in cancer therapy

By Carew Jennifer

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 17-27

Springer Publishing Company

Access to resources Recommend Favorite